
GLP-1 and obesity medicine news.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 438 | Founded | a year ago | Last Issue | 6 days ago |
| Active | |||||

In just a few days, millions of Medicare beneficiaries who have been locked out of obesity treatment could gain access to GLP-1 medications for as little as $50 per month.
On this week’s On The Pen Podcast, I sat down with obesity medicine...
Last week, On The Pen reported that Eli Lilly was working with the FDA to provide retatrutide through the agency’s expanded access, or compassionate use, pathway. This week, it happened.
According to STAT, a 79-year-old man has become the...
Here’s What Patients Should Watch.
A new letter from Senator Jim Banks to Acting FDA Commissioner Kyle Diamantas may offer the clearest indication yet of where the next phase of GLP-1 enforcement is headed. The Indiana Republican is asking...
ADA 2026 delivered exactly what we expected and then some. New Phase III results. Fresh safety questions. Exciting next-generation therapies. And one growing realization:
The future of obesity medicine is going to be far more complicated t...
The FDA issued another round of warning letters to telehealth companies last week, and published them today alongside a warning to telehealth companies. But buried beneath the headlines is a signal that could be more important than the lett...
Subscribers, engagement, traffic and sponsorship for ON THE PEN.
| Subscribers | Engagement | 82 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where ON THE PEN ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 182 | Monthly Search Traffic | Top Keywords |
|---|
How this newsletter ranks in the official Substack charts.
| #190 | |
| #121 |
The writers behind this newsletter.
On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. On The Pen is a top Substack best-seller.
Building a resource for useful, actionable, and grounded in real-life lifestyle upgrades. Guest writer for https://onthepen.substack.com/
You can find recent issues that have been published by ON THE PEN on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to ON THE PEN, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch ON THE PEN as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact ON THE PEN using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like ON THE PEN. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.